{
    "nctId": "NCT06484725",
    "briefTitle": "Oncotype DX in BRCA-mutated Breast Cancer Patients: Our Experience. A Retrospective Observational Monocentric Study",
    "officialTitle": "Oncotype DX in BRCA-mutated Breast Cancer Patients: Our Experience. A Retrospective Observational Monocentric Study",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Genetic Predisposition",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 250,
    "primaryOutcomeMeasure": "Oncotype DX assay and RS\u00ae in participants.",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age at diagnosis at least 18 years\n* Women who underwent breast surgery in OSR\n* Patients with ER-positive, HER2-unamplified early-stage BC who underwent the Oncotype DX assay, according to the standard of care.\n\nExclusion Criteria:\n\n* Male\n* ER negative or HER2 amplified disease\n* Patient s who did not undergo breast surgery in OSR\n* Patient s who did not undergo the Oncotype Dx assay",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}